|
![]() |
|
|
Beclomethasone
drug data and news
Beclomethasone drug data, resources, and news articles (when available). Onconews.org provides news on cancer research. This section, which includes profiles on medicines that may or not be cancer-related is in beta form. If things run smoothly we will be releasing a new format late in the summer of 2006.
|
| Generic name | Beclomethasone | ||
| Brand Names/Synonyms | Aerobec; Aldecin; Anceron; Andion; Beclacin; Becloforte; Beclomet; Beclometasona [Inn-Spanish]; Beclometasondipropionat Mikron; Beclometasondipropionat Mikron.; Beclometasone; Beclometasonum [Inn-Latin]; Beclomethasone; Beclorhinol; Becloval; Beclovent; Becodisks; Beconase; Beconase Aq; Beconasol; Becotide; Clenil-A; Entyderma; Inalone; Korbutone; Propaderm; Qvar; Qvar 80; Rino-Clenil; Sanasthmax; Sanasthmyl; Vancenase; Vancenase Aq; Vanceril; Vanceril Double Strength; Viarex; Viarox | ||
| Indication | For the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older | ||
| Sponsored links | Description | Not Available | |
| Pharmacology | Beclomethasone, a synthetic halogenated glucocorticoid with antiinflammatory and vasoconstrictive effects, is used for treating steroid-dependent asthma, allergic or nonallergic rhinitis, or recurrent nasal polyps. | ||
| Mechanism Of Action | Unbound corticosteroids cross cell membranes and bind with high affinity to specific cytoplasmic receptors. The result includes inhibition of leukocyte infiltration at the site of inflammation, interference in the function of mediators of inflammatory response, suppression of humoral immune responses, and reduction in edema or scar tissue. The antiinflammatory actions of corticosteroids are thought to involve phospholipase A2 inhibitory proteins, lipocortins, which control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes. | ||
| Beclomethasone News (When available) |
Weight May Influence Asthma Care 06 Mar 2006 Oral Beclomethasone Dipropionate Controls Gastrointestinal Graft ... Feb 21, 2006 Singulair pill shows more promise for obese people Feb 23, 2006 DOR BioPharma Presents Positive New Survival Findings from Phase ... Feb 21, 2006 DOR BioPharma Presents Positive New Survival Findings from Phase ... Feb 21, 2006 Asthma Control May Be Weighty Matter Feb 23, 2006 Asthmatic's Weight Determines Medication Feb 26, 2006 Obesity makes asthma harder to treat Feb 22, 2006 orBec® Improves Survival in Patients with Intestinal Graft-Versus ... Feb 21, 2006 Generic Pharmaceutical Association Feb 17, 2006 DOR BioPharma Provides Financial Guidance and Update on European ... Feb 8, 2006 New Guidelines Released for Managing Cough Feb 14, 2006 Refractory Asthma May Respond to TNF-Alpha Inhibition Feb 16, 2006 DOR BioPharma Provides Financial Guidance and Update on European ... Feb 8, 2006 DOR BioPharma Reports Positive New Survival Findings from ... Jan 20, 2006 Breathe Deep Jan 20, 2006 Breathe Easier! Jan 22, 2006 Beximco Pharma begins exporting medicines to Sri Lanka Jan 20, 2006 Allergic rhinitis key to asthma control Dec 10, 2005 DOR BioPharma Maintains AMEX Listing Dec 10, 2005 Rigel Announces Disappointing Results from Phase II Study of R112 ... Dec 1, 2005 Rigel allergy drug fades in Phase 2 trial Dec 1, 2005 Dr. Chris Dale, Vice President, Technology, Cambrex ... Sep 15, 2005 Inyx Updates Financial Guidance for 2005 and 2006 Sep 13, 2005 Nasal Sprays Sep 24, 2005 How do you spell relief for what ails you? Sep 14, 2005 A Review of Pregnancy Outcomes After Exposure to Orally Inhaled or ... Aug 12, 2005 FDA Approvals: Invader UGT1A1, SelectSecure Model 3830, Duet ... Aug 26, 2005 Comparative Phase II Clinical Trial of R112 for Allergy Treatment Aug 10, 2005 When an Asthma Drug Has an Inferiority Complex: A Noninferiority ... Aug 14, 2005 DOR BioPharma and Dowpharma Enter Into a Joint Development ... Jul 26, 2005 Vaccine Researchers Combat Biothreat Agents; Preclinical Safety ... Jul 5, 2005 DOR BioPharma to Present at the Rodman & Renshaw Techvest 2nd ... Jun 13, 2005 | ||
| Dosage Forms | Oral inhalation; Nasal inhalation; Nasal Spray | ||
| Drug_Category | Antiarrhythmic Agents; Glucocorticoids; Anti-inflammatory Agents; Corticosteroids; ATC:A07EA07; ATC:D07AC15; ATC:R01AD01; ATC:R03BA01 | ||
| Absorption | mean peak plasma concentration was 88pg/ml at 0.5 hour | ||
| Interactions |
Interactions for Beclomethasone: Albuterol, Antihistamines, antidiabetic drugs, diuretics, digitalis. | ||
| Toxicity | The acute toxicity of beclomethasone dipropionate is low. The only harmful effect that follows inhalation of large amounts of the drug over a short period of time is suppression of hypothalamic-pituitary-adrenal (HPA) function. Chronic: The excessive use of beclomethasone dipropionate over a long period could lead to adrenal suppression. | ||
| Organisms Affected | Humans and other mammals | ||
| Chemical IUPAC Name | [9-chloro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-(2-propanoyloxyacetyl)-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate | ||
| Chemical Formula | C28H37ClO7 | ||
| Molecular Weight | 521.042 g/mol | ||
| Smiles String | CCC(=O)OCC(=O)C1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)Cl)O)C)C)OC(=O)CC | ||
| Melting Point | 117-120°C | ||
| Water Solubility | 49.39 mg/L | ||
| State | Crystals | ||
| LogP/Hphobicity | 3.795 | ||
| Isoelectric Point | Not Available | ||
| Biotransformation | undergoes rapid and extensive conversion to beclomenthasone-17-monopropionate (17-BMP) during absorption | ||
| Half Life | 2.8 hours | ||
| Protein Binding [%] | 87 % to albumin and transcortin | ||
| RxList Link | RXlist | ||
| Sponsored links | |||
| Drug Reference |
http://www.drugs.com/cons/Beclomethasone.html http://www.rxlist.com/cgi/generic2/qvar.htm | ||
| Drug Type | Approved Drug | ||
| Accession No | APRD00564 | ||
| CAS Registry Number | 4419-39-0 | ||
| KEGG Compound ID | C06842 | ||
| PubChem ID | SID:270219 | ||
| PharmGKB ID | PA448547 | ||
| SwissProt ID | Not Available | ||
| GenBank ID | Not Available | ||
| Drug ID Number [DIN] | 2238796 |
|
Home | About | Cancers | Treatment | Medications Copyright onconews.org 2005. All Rights Reserved. |